American Kidney Fund Commends Congress for Including Vital Immunosuppressive Drug Coverage for Kidney Transplant Recipients in End-Of-Year Legislative Package
December 23, 2020
December 23, 2020
ROCKVILLE, Maryland, Dec. 23 -- The American Kidney Fund issued the following statement:
* * *
The following statement may be attributed to LaVarne A. Burton, president and CEO of the American Kidney Fund:
"The American Kidney Fund (AKF) commends Congress for approving a legislative package that includes giving kidney transplant recipients comprehensive immunosuppressive drug coverage. AKF and all Ambassadors in the AKF Advocacy Network have worked dil . . .
* * *
The following statement may be attributed to LaVarne A. Burton, president and CEO of the American Kidney Fund:
"The American Kidney Fund (AKF) commends Congress for approving a legislative package that includes giving kidney transplant recipients comprehensive immunosuppressive drug coverage. AKF and all Ambassadors in the AKF Advocacy Network have worked dil . . .